Tamarack Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Tamarack Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-400,000	Closed	-$24.9M	–	41
2015 Q1	$24.9M	Buy	400,000 +15,000	+4%	+$872K	3.28%	10
2014 Q4	$22.1M	Buy	385,000 +155,000	+67%	+$8.64M	3.36%	9
2014 Q3	$12.4M	Sell	230,000 -16,500	-7%	-$874K	2.74%	13
2014 Q2	$13.3M	Buy	+246,500	New	+$12.6M	2.71%	11

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Tamarack Capital Management's TEVA Position: Q2 2015 in Review

Tamarack Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2015, closing a stake of 400,000 shares — an estimated $24.9M sold.

Tamarack Capital Management first reported a position in TEVA in Q2 2014 and held it in 4 quarters. The position peaked at $24.9M in Q1 2015. 819 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

Tamarack Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2015 after selling out during the quarter.
Tamarack Capital Management sold 400,000 Teva Pharmaceutical Industries Limited shares in Q2 2015, an estimated $24.9M.
Tamarack Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2014 and held it in 4 quarters.
Tamarack Capital Management's Teva Pharmaceutical Industries Limited position peaked at $24.9M in Q1 2015.
819 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2015.

Based on Tamarack Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.